标题/作者	年份
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy M Carbone, PS Adusumilli, HR Alexander Jr, P Baas, F Bardelli, A Bononi, ... CA: a cancer journal for clinicians 69 (5), 402-429	2019
ERS/EACTS statement on the management of malignant pleural effusions AC Bibby, P Dorn, I Psallidas, JM Porcel, J Janssen, M Froudarakis, ... European journal of cardio-thoracic surgery 55 (1), 116-132	2019
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma A Scherpereel, I Opitz, T Berghmans, I Psallidas, M Glatzer, D Rigau, ... European respiratory journal 55 (6)	2020
EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach AG Nicholson, JL Sauter, AK Nowak, HL Kindler, RR Gill, M Remy-Jardin, ... Journal of Thoracic Oncology 15 (1), 29-49	2020
Update on immunohistochemistry for the diagnosis of lung cancer K Inamura Cancers 10 (3), 72	2018
Biomarkers in the diagnosis of pleural diseases: a 2018 update JM Porcel Therapeutic advances in respiratory disease 12, 1753466618808660	2018
Asbestos, smoking and lung cancer: an update S Klebe, J Leigh, DW Henderson, M Nurminen International journal of environmental research and public health 17 (1), 258	2020
Application of immunohistochemistry in diagnosis and management of malignant mesothelioma DB Chapel, JJ Schulte, AN Husain, T Krausz Translational lung cancer research 9 (Suppl 1), S3	2020
New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the international mesothelioma panel from the MESOPATH reference center FG Salle, N Le Stang, AG Nicholson, D Pissaloux, A Churg, S Klebe, ... Journal of thoracic oncology 13 (8), 1189-1203	2018
Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention S Toyokuni Free Radical Biology and Medicine 133, 206-215	2019
Malignant peritoneal mesothelioma: a review G Broeckx, P Pauwels Translational lung cancer research 7 (5), 537	2018
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up S Kusamura, V Kepenekian, L Villeneuve, RJ Lurvink, K Govaerts, ... European Journal of Surgical Oncology 47 (1), 36-59	2021
New perspectives on diagnosis and therapy of malignant pleural mesothelioma M Rossini, P Rizzo, I Bononi, A Clementz, R Ferrari, F Martini, MG Tognon Frontiers in oncology 8, 91	2018
Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience P Loveland, M Christie, G Hammerschlag, L Irving, D Steinfort Internal medicine journal 48 (11), 1318-1324	2018
An algorithmic immunohistochemical approach to define tumor type and assign site of origin AM Bellizzi Advances in anatomic pathology 27 (3), 114	2020
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ S Popat, P Baas, C Faivre-Finn, N Girard, AG Nicholson, AK Nowak, ... Annals of Oncology 33 (2), 129-142	2022
The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review G Alì, R Bruno, G Fontanini Journal of thoracic disease 10 (Suppl 2), S276	2018
The immune microenvironment in mesothelioma: mechanisms of resistance to immunotherapy GJ Chu, N Van Zandwijk, JEJ Rasko Frontiers in Oncology 9, 1366	2019
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center AM Marchevsky, N LeStang, K Hiroshima, G Pelosi, R Attanoos, A Churg, ... Human pathology 67, 160-168	2017
Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications F Forest, A Patoir, P Dal Col, A Sulaiman, F Camy, D Laville, ... Pathology 50 (6), 635-641	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。